17-216
Showing 1 - 25 of 5,325
Focal Segmental Glomerulosclerosis (FSGS) Trial in Worldwide (PF-06730512)
Active, not recruiting
- Focal Segmental Glomerulosclerosis (FSGS)
-
Birmingham, Alabama
- +59 more
Aug 17, 2022
Advanced Non Small Cell Lung Cancer, Advanced (Inoperable) Non Small Cell Lung Cancer Trial in Worldwide (Pharmacokinetic
Active, not recruiting
- Advanced Non Small Cell Lung Cancer
- Advanced (Inoperable) Non Small Cell Lung Cancer
- Pharmacokinetic sampling
- +2 more
-
San Diego, California
- +15 more
Feb 21, 2022
Healthy Volunteers Trial in Shanghai (BAY1817080, Placebo)
Completed
- Healthy Volunteers
- BAY1817080
- Placebo
-
Shanghai, ChinaZhongshan Hospital, Fudan University
Oct 18, 2022
Mantle Cell Lymphoma, Lymphoma Trial in United States (BR-I (bendamustine, rituximab, ibrutinib), VEN (Venetoclax))
Active, not recruiting
- Mantle Cell Lymphoma
- Lymphoma
- BR-I (bendamustine, rituximab, ibrutinib)
- VEN (Venetoclax)
-
Basking Ridge, New Jersey
- +6 more
Feb 3, 2022
Preclinical Alzheimer's Disease, Early Preclinical Alzheimer's Disease Trial in Worldwide (Lecanemab, Placebo)
Recruiting
- Preclinical Alzheimer's Disease
- Early Preclinical Alzheimer's Disease
- Lecanemab
- Placebo
-
Birmingham, Alabama
- +103 more
Jun 14, 2022
Integrated Proteomic HPLC-ESI-MS Analysis of Salivary Peptides
Active, not recruiting
- Bronchopulmonary Dysplasia; Retinopathy of Prematurity
- Integrated proteomic HPLC-ESI-MS analysis of salivary peptides
-
Roma, ItalyFondazione Policlinico Universitario A. Gemelli IRCCS
Mar 13, 2023
Inflammation Corneal, Pain, Postoperative Trial in United States (OCS-01 - Dexamethasone Cyclodextrin Nanoparticle Ophthalmic
Completed
- Inflammation Corneal
- Pain, Postoperative
- OCS-01 - Dexamethasone Cyclodextrin Nanoparticle Ophthalmic Suspension 1.5% mg/mL
- Placebo
-
Petaluma, California
- +3 more
Feb 17, 2022
Heathly Subjects Trial in Seoul (Single subcutaneous administration and Blood collection, Single subcutaneous administration and
Recruiting
- Heathly Subjects
- Single subcutaneous administration and Blood collection
- +2 more
-
Seoul, Korea, Republic ofSeoul National University
Oct 5, 2022
Advanced BRAFV600 Wild-type Melanoma Trial in Worldwide (Cobimetinib, Atezolizumab, Pembrolizumab)
Terminated
- Advanced BRAFV600 Wild-type Melanoma
- Cobimetinib
- +2 more
-
Tucson, Arizona
- +120 more
Aug 24, 2022
Atrial Fibrillation, Left Atrial Appendage Thrombosis Trial in Cleveland (Intracardiac Echocardiography (ICE))
Recruiting
- Atrial Fibrillation
- Left Atrial Appendage Thrombosis
- Intracardiac Echocardiography (ICE)
-
Cleveland, OhioCleveland Clinic
Aug 29, 2023
Perianal Fistula Due to Crohn's Disease (Disorder) Trial in Cleveland (Mesenchymal stem cells)
Recruiting
- Perianal Fistula Due to Crohn's Disease (Disorder)
- Mesenchymal stem cells
-
Cleveland, OhioCleveland Clinic
Apr 1, 2022
Non Hodgkin Lymphoma Trial in Cleveland (UF-KURE19 CAR-T cells, Fludarabine, Cyclophosphamide)
Recruiting
- Non Hodgkin Lymphoma
- UF-KURE19 CAR-T cells
- +2 more
-
Cleveland, Ohio
- +1 more
Nov 21, 2022
Hypertension Trial in Warrensville Heights (Therapeutic yoga)
Recruiting
- Hypertension
- Therapeutic yoga
-
Warrensville Heights, OhioSouth Pointe Hospital
Nov 30, 2023
Plaque Psoriasis Trial in Beijing (HLX03, adalimumab)
Completed
- Plaque Psoriasis
-
Beijing, ChinaPeking University People's Hospital
May 4, 2022
Friedreich Ataxia Trial in Eatontown (DT-216, DT-216 matching Placebo)
Recruiting
- Friedreich Ataxia
- DT-216
- DT-216 matching Placebo
-
Eatontown, New JerseyClinilabs
Apr 4, 2022
Spinal Cord Injury, Paralysis, Tetraplegia Trial in Cleveland (IRS-8 (8-Channel implanted stimulator-telemeter))
Recruiting
- Spinal Cord Injury
- +3 more
- IRS-8 (8-Channel implanted stimulator-telemeter)
-
Cleveland, OhioLouis Stokes VA Medical Center, Cleveland, OH
Jan 5, 2023
Healthy Trial in Darmstadt (Tepotinib test (Treatment Period 1), Tepotinib reference (Treatment Period 2), Tepotinib reference
Completed
- Healthy
- Tepotinib test (Treatment Period 1)
- +3 more
-
Darmstadt, GermanyFor Recruiting Locations outside US, please Contact Merck KGaA C
Aug 22, 2022
Perforated Appendicitis Trial in Huntington (Appendectomy, Observation)
Recruiting
- Perforated Appendicitis
- Appendectomy
- Observation
-
Huntington, West VirginiaMarshall University School of Medicine
Aug 22, 2022
Healthy Subjects, Obesity, T2DM (Type 2 Diabetes) Trial in Changchun (HEC88473 injection, Placebo)
Completed
- Healthy Subjects
- +2 more
- HEC88473 injection
- Placebo
-
Changchun, Jilin, ChinaThe First Hospital of Jilin University
Jul 14, 2023